Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

BACKGROUND: Early diagnosis can significantly improve treatment outcomes for hepatocellular carcinoma (HCC) patients. Currently, the dosage of serum alpha fetoprotein (AFP) is widely used in the diagnosis of HCC, but this biomarker has low specificity and may cause false positive or false negative r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian, Zhu, Yue, Li, Yi, Liu, Kun, He, Fei, Xu, Sihuan, Li, Xin, Li, Li, Hu, Junfang, Liu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111940/
https://www.ncbi.nlm.nih.gov/pubmed/33971914
http://dx.doi.org/10.1186/s13027-021-00367-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111940/
https://www.ncbi.nlm.nih.gov/pubmed/33971914
http://dx.doi.org/10.1186/s13027-021-00367-2

Ejemplares similares